ID 3CPBA STANDARD; PRT; 314 AA. DT CONVERTED FROM PDB (SEQRES) 3CPB DE Vascular endothelial growth factor receptor 2 OS Homo sapiens CC EXPDTA X-RAY DIFFRACTION CC RESOLU 2.700 CC R-Factor 0.219 FT #SUB 17 831 ARG A 45 859 THR B Protein S 1 FT #SUB 17 831 ARG A 46 860 ALA B Protein A 2 FT #SUB 17 831 ARG A 47 861 THR B Protein B 4 FT #SUB 17 831 ARG A 48 862 CYS B Protein B 1 FT #SUB 18 832 ASP A 40 854 PHE B Protein A 4 FT #SUB 18 832 ASP A 46 860 ALA B Protein A 3 FT #SUB 18 832 ASP A 47 861 THR B Protein B 1 FT #SUB 18 832 ASP A 48 862 CYS B Protein B 2 FT #SUB 20 834 LEU A 47 861 THR B Protein B 2 FT #SUB 20 834 LEU A 48 862 CYS B Protein B 6 FT #SUB 21 835 LYS A 38 852 ASP B Protein S 6 FT #SUB 21 835 LYS A 48 862 CYS B Protein A 4 FT #SUB 21 835 LYS A 50 864 THR B Protein S 3 FT #SUB 22 836 LEU A 45 859 THR B Protein S 3 FT #SUB 22 836 LEU A 47 861 THR B Protein S 1 FT #SUB 24 838 LYS A 174 1038 GLU B Protein S 2 FT #SUB 55 869 MET A 45 859 THR B Protein S 1 FT #SUB 58 872 GLU A 44 858 LYS B Protein S 4 FT #SUB 95 909 GLY A 46 860 ALA B Protein B 1 FT #SUB 97 911 PRO A 44 858 LYS B Protein S 2 FT #SUB 97 911 PRO A 45 859 THR B Protein S 4 FT #SUB 99 913 MET A 45 859 THR B Protein S 2 FT #SUB 99 913 MET A 47 861 THR B Protein S 1 FT #HET 26 840 LEU A 1 1 C92 A S 1 FT #HET 34 848 VAL A 1 1 C92 A S 1 FT #HET 52 866 ALA A 1 1 C92 A A 6 FT #HET 53 867 VAL A 1 1 C92 A B 1 FT #HET 54 868 LYS A 1 1 C92 A A 5 FT #HET 71 885 GLU A 1 1 C92 A S 9 FT #HET 74 888 ILE A 1 1 C92 A S 1 FT #HET 75 889 LEU A 1 1 C92 A S 4 FT #HET 84 898 VAL A 1 1 C92 A S 1 FT #HET 85 899 VAL A 1 1 C92 A S 1 FT #HET 100 914 VAL A 1 1 C92 A A 2 FT #HET 102 916 THR A 1 1 C92 A S 11 FT #HET 103 917 GLU A 1 1 C92 A B 2 FT #HET 104 918 PHE A 1 1 C92 A A 3 FT #HET 105 919 CYS A 1 1 C92 A A 4 FT #HET 155 1019 LEU A 1 1 C92 A S 1 FT #HET 171 1035 LEU A 1 1 C92 A S 7 FT #HET 181 1045 CYS A 1 1 C92 A A 3 FT #HET 182 1046 ASP A 1 1 C92 A A 7 FT #HET 183 1047 PHE A 1 1 C92 A S 5 FT DISORDER 1 4 FT DISORDER 27 32 FT DISORDER 184 202 CC SEQUENCE 285 AA (ATOM); CC RLPYDASKWE FPRDRLKLGK PLQVIEADAF GIDKTATCRT VAVKMLKEGA THSEHRALMS CC ELKILIHIGH HLNVVNLLGA CTKPGGPLMV ITEFCKFGNL STYLRSKRNE FVPYKVAPED CC LYKDFLTLEH LICYSFQVAK GMEFLASRKC IHRDLAARNI LLSEKNVVKI CDFLPLKWMA CC PETIFDRVYT IQSDVWSFGV LLWEIFSLGA SPYPGVKIDE EFCRRLKEGT RMRAPDYTTP CC EMYQTMLDCW HGEPSQRPTF SELVEHLGNL LQANAQQDRH HHHHH CC !---- CC ALIGNMENT OF SEQRES AND ATOMRES CC SEQRES EHAERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRT CC ATOM ----RLPYDASKWEFPRDRLKLGKPL------QVIEADAFGIDKTATCRT CC ********************** ****************** CC SEQRES VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMV CC ATOM VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMV CC ************************************************** CC SEQRES ITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAK CC ATOM ITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAK CC ************************************************** CC SEQRES GMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD CC ATOM GMEFLASRKCIHRDLAARNILLSEKNVVKICDF----------------- CC ********************************* CC SEQRES ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE CC ATOM --LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE CC ************************************************ CC SEQRES FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL CC ATOM FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL CC ************************************************** CC SEQRES QANAQQDRHHHHHH CC ATOM QANAQQDRHHHHHH CC ************** SQ SEQUENCE 314 AA; MW; CN; EHAERLPYDA SKWEFPRDRL KLGKPLGRGA FGQVIEADAF GIDKTATCRT VAVKMLKEGA THSEHRALMS ELKILIHIGH HLNVVNLLGA CTKPGGPLMV ITEFCKFGNL STYLRSKRNE FVPYKVAPED LYKDFLTLEH LICYSFQVAK GMEFLASRKC IHRDLAARNI LLSEKNVVKI CDFGLARDIY KDPDYVRKGD ARLPLKWMAP ETIFDRVYTI QSDVWSFGVL LWEIFSLGAS PYPGVKIDEE FCRRLKEGTR MRAPDYTTPE MYQTMLDCWH GEPSQRPTFS ELVEHLGNLL QANAQQDRHH HHHH // ID 3CPBB STANDARD; PRT; 314 AA. DT CONVERTED FROM PDB (SEQRES) 3CPB DE Vascular endothelial growth factor receptor 2 OS Homo sapiens CC EXPDTA X-RAY DIFFRACTION CC RESOLU 2.700 CC R-Factor 0.219 FT #SUB 38 852 ASP B 21 835 LYS A Protein S 6 FT #SUB 40 854 PHE B 18 832 ASP A Protein S 4 FT #SUB 44 858 LYS B 58 872 GLU A Protein A 4 FT #SUB 44 858 LYS B 97 911 PRO A Protein B 2 FT #SUB 45 859 THR B 17 831 ARG A Protein B 1 FT #SUB 45 859 THR B 22 836 LEU A Protein S 3 FT #SUB 45 859 THR B 55 869 MET A Protein S 1 FT #SUB 45 859 THR B 97 911 PRO A Protein B 4 FT #SUB 45 859 THR B 99 913 MET A Protein A 2 FT #SUB 46 860 ALA B 17 831 ARG A Protein B 2 FT #SUB 46 860 ALA B 18 832 ASP A Protein B 3 FT #SUB 46 860 ALA B 95 909 GLY A Protein S 1 FT #SUB 47 861 THR B 17 831 ARG A Protein A 4 FT #SUB 47 861 THR B 18 832 ASP A Protein B 1 FT #SUB 47 861 THR B 20 834 LEU A Protein A 2 FT #SUB 47 861 THR B 22 836 LEU A Protein S 1 FT #SUB 47 861 THR B 99 913 MET A Protein S 1 FT #SUB 48 862 CYS B 17 831 ARG A Protein B 1 FT #SUB 48 862 CYS B 18 832 ASP A Protein A 2 FT #SUB 48 862 CYS B 20 834 LEU A Protein A 6 FT #SUB 48 862 CYS B 21 835 LYS A Protein B 4 FT #SUB 50 864 THR B 21 835 LYS A Protein S 3 FT #SUB 174 1038 GLU B 24 838 LYS A Protein S 2 FT #HET 34 848 VAL B 2 2 C92 B S 3 FT #HET 52 866 ALA B 2 2 C92 B A 6 FT #HET 54 868 LYS B 2 2 C92 B A 3 FT #HET 71 885 GLU B 2 2 C92 B S 6 FT #HET 78 892 ILE B 2 2 C92 B S 1 FT #HET 85 899 VAL B 2 2 C92 B S 1 FT #HET 100 914 VAL B 2 2 C92 B A 2 FT #HET 102 916 THR B 2 2 C92 B S 8 FT #HET 103 917 GLU B 2 2 C92 B B 2 FT #HET 104 918 PHE B 2 2 C92 B A 4 FT #HET 105 919 CYS B 2 2 C92 B A 10 FT #HET 155 1019 LEU B 2 2 C92 B S 1 FT #HET 171 1035 LEU B 2 2 C92 B S 4 FT #HET 181 1045 CYS B 2 2 C92 B A 3 FT #HET 182 1046 ASP B 2 2 C92 B A 8 FT #HET 183 1047 PHE B 2 2 C92 B S 2 FT DISORDER 1 5 FT DISORDER 27 31 FT DISORDER 57 59 FT DISORDER 126 132 FT DISORDER 185 202 FT DISORDER 302 314 CC SEQUENCE 263 AA (ATOM); CC LPYDASKWEF PRDRLKLGKP LGQVIEADAF GIDKTATCRT VAVKMLATHS EHRALMSELK CC ILIHIGHHLN VVNLLGACTK PGGPLMVITE FCKFGNLSTY LRSKRNEFVP YKKDFLTLEH CC LICYSFQVAK GMEFLASRKC IHRDLAARNI LLSEKNVVKI CDFGLPLKWM APETIFDRVY CC TIQSDVWSFG VLLWEIFSLG ASPYPGVKID EEFCRRLKEG TRMRAPDYTT PEMYQTMLDC CC WHGEPSQRPT FSELVEHLGN LLQ CC !---- CC ALIGNMENT OF SEQRES AND ATOMRES CC SEQRES EHAERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRT CC ATOM -----LPYDASKWEFPRDRLKLGKPL-----GQVIEADAFGIDKTATCRT CC ********************* ******************* CC SEQRES VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMV CC ATOM VAVKML---ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMV CC ****** ***************************************** CC SEQRES ITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAK CC ATOM ITEFCKFGNLSTYLRSKRNEFVPYK-------KDFLTLEHLICYSFQVAK CC ************************* ****************** CC SEQRES GMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD CC ATOM GMEFLASRKCIHRDLAARNILLSEKNVVKICDFG---------------- CC ********************************** CC SEQRES ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE CC ATOM --LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE CC ************************************************ CC SEQRES FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL CC ATOM FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL CC ************************************************** CC SEQRES QANAQQDRHHHHHH CC ATOM Q------------- CC * SQ SEQUENCE 314 AA; MW; CN; EHAERLPYDA SKWEFPRDRL KLGKPLGRGA FGQVIEADAF GIDKTATCRT VAVKMLKEGA THSEHRALMS ELKILIHIGH HLNVVNLLGA CTKPGGPLMV ITEFCKFGNL STYLRSKRNE FVPYKVAPED LYKDFLTLEH LICYSFQVAK GMEFLASRKC IHRDLAARNI LLSEKNVVKI CDFGLARDIY KDPDYVRKGD ARLPLKWMAP ETIFDRVYTI QSDVWSFGVL LWEIFSLGAS PYPGVKIDEE FCRRLKEGTR MRAPDYTTPE MYQTMLDCWH GEPSQRPTFS ELVEHLGNLL QANAQQDRHH HHHH //